GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invuity Inc (NAS:IVTY) » Definitions » Current Ratio

Invuity (Invuity) Current Ratio : 2.13 (As of Jun. 2018)


View and export this data going back to 2015. Start your Free Trial

What is Invuity Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Invuity's current ratio for the quarter that ended in Jun. 2018 was 2.13.

Invuity has a current ratio of 2.13. It generally indicates good short-term financial strength.

The historical rank and industry rank for Invuity's Current Ratio or its related term are showing as below:

IVTY's Current Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.715
* Ranked among companies with meaningful Current Ratio only.

Invuity Current Ratio Historical Data

The historical data trend for Invuity's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invuity Current Ratio Chart

Invuity Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17
Current Ratio
3.96 2.98 8.40 5.16 2.55

Invuity Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.07 2.90 2.55 3.38 2.13

Competitive Comparison of Invuity's Current Ratio

For the Medical Instruments & Supplies subindustry, Invuity's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invuity's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invuity's Current Ratio distribution charts can be found below:

* The bar in red indicates where Invuity's Current Ratio falls into.



Invuity Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Invuity's Current Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Current Ratio (A: Dec. 2017 )=Total Current Assets (A: Dec. 2017 )/Total Current Liabilities (A: Dec. 2017 )
=37.314/14.636
=2.55

Invuity's Current Ratio for the quarter that ended in Jun. 2018 is calculated as

Current Ratio (Q: Jun. 2018 )=Total Current Assets (Q: Jun. 2018 )/Total Current Liabilities (Q: Jun. 2018 )
=40.933/19.211
=2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invuity  (NAS:IVTY) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Invuity Current Ratio Related Terms

Thank you for viewing the detailed overview of Invuity's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Invuity (Invuity) Business Description

Traded in Other Exchanges
N/A
Address
Invuity Inc is a United States-based commercial-stage medical technology company which utilizes its proprietary Intelligent Photonics technology to develop single-use and reusable illuminated surgical devices. It provides surgeons with illumination and direct visualization of surgical cavities during open minimally invasive and minimal access procedures. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System, Waveguide XT System, among others. It sells directly to hospitals, surgeons typically drive the purchasing decision.
Executives
Gregory T Lucier director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Eric W Roberts director VALENCE LIFE SCIENCES LLC, 500 PARK AVENUE 9TH FLOOR, NEW YORK NY 10022
William W Burke director 3868 MOCKINGBIRD LN, DALLAS TX 75205
Randall A Lipps director 1101 EAST MEADOW DR, PALO ALTO CA 94303
Dan Wolterman director 3721 VALLEY CENTRE DR, SUITE 500, SAN DIEGO CA 92130
James H Mackaness officer: Chief Financial Officer 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Reza Zadno director 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Douglas A Pepper 10 percent owner C/O INTERWEST PARTNERS, 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Philip T Gianos 10 percent owner 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Keval Desai 10 percent owner 467 FIRST STREET, SUITE 201, LOS ALTOS X1 94022
Interwest Partners X Lp 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022